Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for severe asthma attack in the emergency department
IRCT20131118015446N14Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Dexmedetomidine plus standard treatment with Normal saline placebo plus standard treatment (2 arms). Primary endpoints: Peak expiratory flow rate and Forced expiratory volume in 1 second. Started Apr 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20131118015446N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131118015446N14.